SE
60
-5
FDX
54
14
CAH
60
2
UHS
54
-4
AON
60
2
XRX
34
-3
UPS
50
9
NKE
33
2
STZ
58
3
SRE
66
-3
GOOG
69
-10
RCL
88
-2
HCP
70
-4
NTAP
61
-3
AA
38
-2
MA
67
-5
GPC
40
2
EMC
53
-3
OI
43
-2
EMR
77
-2
SE
60
-5
FDX
54
14
CAH
60
2
UHS
54
-4
AON
60
2
XRX
34
-3
UPS
50
9
NKE
33
2
STZ
58
3
SRE
66
-3
GOOG
69
-10
RCL
88
-2
HCP
70
-4
NTAP
61
-3
AA
38
-2
MA
67
-5
GPC
40
2
EMC
53
-3
OI
43
-2
EMR
77
-2
Financhill
Back

Axsome Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
82

AXSM
Axsome Therapeutics

Last Price:
97.38
Seasonality Move:
52.64%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Axsome Therapeutics Price Quote

$97.38
-0.45 (-0.46%)
(Updated: November 14, 2024 at 5:35 PM ET)

Axsome Therapeutics Key Stats

Buy
82
Axsome Therapeutics (AXSM) is a Buy
Day range:
$97.74 - $105.00
52-week range:
$56.66 - $101.51
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.16
P/B ratio:
46.43%
Volume:
1.2M
Avg. volume:
481.9K
1-year change:
64.95%
Market cap:
$4.8B
Revenue:
$270.6M
EPS:
$-6.51

How Much Does Axsome Therapeutics Make?

Is Axsome Therapeutics Growing As A Company?

  • What Is Axsome Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.87%
  • What Is Axsome Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Axsome Therapeutics Stock Price Performance

What Is Axsome Therapeutics 52-Week High & Low?

Axsome Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Axsome Therapeutics?

Is Axsome Therapeutics Cash Flow Positive?

  • What Is AXSM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$167.5M
  • What Is Axsome Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $46.6M
  • What Is Axsome Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$528K

Axsome Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    AXSM return on invested capital is -82.21%
  • What Is Axsome Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -53.3%
  • What Is AXSM Return On Equity?
    ROE is a measure of profitability and is -156.44%

Axsome Therapeutics Earnings Date & Stock Price

Axsome Therapeutics Competitors

Axsome Therapeutics Dividend Yield

Axsome Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.49%
Revenue: 86.65% 6.82%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 126.00
Upside from Last Price: 28.79%

Major Shareholders

  • How many AXSM shares are owned by institutional investors?
    58.2M AXSM shares are owned by institutional investors
  • How many AXSM shares are owned by insiders?
    209.5K AXSM shares are owned by insiders